한글목차

신장 내과·비뇨기과의 동향과 예측

세계 신장학 및 비뇨기과 시장의 미래는 병원, 클리닉, 외래수술센터(ASC) 시장에서의 기회로 인해 유망합니다. 세계 신장 및 비뇨기과 시장은 2024-2030년 6.6%의 연평균 복합 성장률(CAGR)로 2030년까지 약 97억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 만성질환의 유병률 증가, 투석 환자 수 증가, 최소침습(MI) 장비에 대한 선호도 증가 등입니다.

• Lucintel의 예측에 따르면 경피적 신장루 카테터는 신장 이식으로 인한 문제 치료, 신장 또는 신주위 체액 저류의 감압, 비확장성 폐색 치료에 주로 사용되므로 제품 카테고리에서 예측 기간 중 가장 높은 성장을 보일 것으로 예상됩니다.
• 최종 용도 카테고리에서 병원은 신장질환 환자의 입원 증가, 고급 치료 장비의 손쉬운 가용성, 의료 시설에서 투석을 받는 환자 증가로 인해 가장 큰 부문으로 남을 것으로 보입니다.
• 지역별로는 북미가 신장질환 환자 증가, 숙련된 의사의 존재 및 확립된 의료 시설의 존재로 인해 예측 기간 중 가장 높은 성장세를 보일 것으로 예상됩니다.

신장내과-비뇨기과 시장의 전략적 성장 기회

다양한 응용 사례 등으로 인해 이 분야는 전략적 성장 기회를 창출하고 있습니다.

• 원격의료 확대: 원격의료 서비스 확대는 환자 관리를 강화할 뿐만 아니라 의료 접근성을 향상시키는 중요한 수단이 될 수 있습니다. 의료 서비스를 충분히 제공받지 못하는 사람들을 위한 서비스 격차를 해소하기 위해 견고한 원격의료 플랫폼을 개발해야 합니다.
• 로봇 수술 시스템: 로봇 수술 시스템에 투자하는 것은 최첨단 수술 솔루션을 제공한다는 점에서 성장의 기회를 제공합니다. 임상 현장에서 비뇨기과 수술의 정확도와 결과를 향상시킵니다.
• 인공 신장 기술의 발전은 투석 시장의 성장 기회로 이어집니다. 즉, 만성 신장질환 관리를 보다 효과적이고 편리하게 하는 것을 목표로 하는 기술 혁신이 이러한 미충족 수요를 충족시킬 수 있다는 것을 의미합니다.
• 개인화 치료 솔루션: 신장학 및 비뇨기과 분야에서는 이러한 환자 데이터를 활용한 개인화된 의료 접근법이 성장할 가능성이 있습니다. 결과적으로 이러한 개발은 치료 성과와 환자 만족도를 향상시킬 수 있을 것으로 기대됩니다.
• 진단 툴의 혁신 : 신장 및 비뇨기 질환의 조기 발견 및 모니터링은 사용 가능한 진단 툴의 유형을 늘림으로써 개선될 수 있습니다. 그 결과, 영상 진단 및 바이오마커 검사의 발전으로 진단 정확도가 향상될 수 있습니다.

이러한 기회는 기술 혁신을 촉진하고 환자 치료를 개선함으로써 신장학 및 비뇨기과 시장을 형성하고 있습니다.

신장내과-비뇨기과 시장 성장 촉진요인 및 과제

신장내과 및 비뇨기과 시장은 다양한 촉진요인의 영향을 받고 있으며, 이는 시장 성장뿐만 아니라 시장 개척에도 영향을 미치는 주요 과제이기도 합니다.

신장학 및 비뇨기과 시장 성장 촉진요인은 다음과 같습니다. :

• 기술 발전: 혁신적인 진단 툴, 수술 기술, 디지털 건강 솔루션의 사용은 이 시장 부문의 성장을 가속할 것입니다. 이러한 개선은 특히 비뇨기과 의사와 관련하여 전체 신장학 치료의 효율성과 효과를 향상시킬 수 있습니다.
• 신장 및 비뇨기 질환 발생률 증가: 신장 및 비뇨기 질환의 유병률이 증가함에 따라 보다 정교한 치료 옵션이 필요하게 되었습니다. 이러한 추세는 새로운 기술과 치료법의 개발 및 보급을 촉진하고 있습니다.
• 맞춤형 의료에 대한 관심 증가: 맞춤형 의료로의 전환은 환자 개개인프로파일에 맞게 의료 요법을 조정하여 치료 결과를 개선하고 있습니다. 비뇨기과뿐만 아니라 신장내과에서도 이러한 방법을 인식하고 있습니다.
• 원격의료 서비스 확대: 원격의료 서비스 증가는 치료에 대한 접근성을 높이고 환자 관리를 개선하고 있습니다. 신장내과와 비뇨기과 치료는 원격 진료와 모니터링을 도입하기 시작했습니다.
• 연구개발 투자 증가: 이 자금은 연구개발에 대한 투자를 통해 신장학 및 비뇨기과 기술 발전을 촉진합니다. 특히 새로운 치료법과 진단 툴의 개발을 지원합니다.

신장내과 및 비뇨기과 시장이 해결해야 할 과제는 다음과 같습니다. :

• 첨단 기술의 높은 비용: 첨단 기술 장비의 높은 가격은 도입에 장애가 될 수 있습니다. 의료 서비스 프로바이더와 환자는 비용과 접근성의 균형을 맞추는 데 어려움을 겪고 있습니다.
• 규제 및 컴플라이언스 문제: 미로와 같은 규제 요건을 협상하면서 표준을 충족하는 것은 문제가 될 수 있습니다. 이는 신제품 시장 진입 및 승인과 같은 문제에 영향을 미칩니다.
• 데이터 프라이버시 우려: 환자 데이터의 보안과 프라이버시를 보장하는 것은 큰 과제입니다. 신뢰를 유지하기 위해서는 데이터 보호 규칙을 준수하고 환자의 요구에 부응하는 것이 필수적입니다.

신장학 및 비뇨기과 시장은 혁신, 구매 결정, 규제 요건에 영향을 미치는 이러한 원동력과 과제에 의해 형성되고 있습니다.

목차

제1장 개요

제2장 세계의 신장 내과·비뇨기과시장 : 시장 역학

• 서론, 배경, 분류
• 공급망
• 업계의 촉진요인과 과제

제3장 2018-2030년 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 신장 내과·비뇨기과 시장 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 신장 내과·비뇨기과시장 : 제품별
  • 요관 카테터
  • PCN 카테터
  • 요관 스텐트
  • 스톤 바스켓
  • 비뇨기과 가이드와이어
  • 신장 확장약
  • 기타
• 세계의 신장 내과·비뇨기과시장 : 용도별
  • 요로결석증
  • 비뇨기암과 전립선 비대증
  • 방광 장애
  • 신장질환
  • 기타
• 세계의 신장 내과·비뇨기과시장 : 최종 용도 산업별
  • 병원
  • 클리닉
  • 외래 수술 센터
  • 기타

제4장 2018-2030년 지역별 시장 동향과 예측 분석

• 지역별 세계 신장 내과·비뇨기과시장
• 북미의 신장 내과·비뇨기과시장
• 유럽의 신장 내과·비뇨기과시장
• 아시아태평양의 신장 내과·비뇨기과시장
• 기타 지역의 신장 내과·비뇨기과시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 업무 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 제품별 세계의 신장 내과·비뇨기과 시장의 성장 기회
  • 애플리케이션별 세계의 신장 내과·비뇨기과 시장의 성장 기회
  • 최종 용도 산업별 세계의 신장 내과·비뇨기과 시장의 성장 기회
  • 세계의 신장 내과·비뇨기과시장 지역의 성장 기회
• 세계의 신장 내과·비뇨기과 시장의 새로운 동향
• 전략 분석
  • 신제품 개발
  • 세계의 신장 내과·비뇨기과 시장의 능력 확대
  • 세계의 신장 내과·비뇨기과시장에서의 합병, 인수, 합병사업
  • 인증과 라이선싱

제7장 주요 기업의 기업 개요

• Medtronic
• Coloplast
• Boston Scientific
• ConvaTec
• B. Braun
• Hollister
• Teleflex
• Baxter
• Fresenius Medical Care
• Asahi Kasei

영문목차

Nephrology and Urology Trends and Forecast

The future of the global nephrology and urology market looks promising with opportunities in the hospital, clinic, and ambulatory surgical center markets. The global nephrology and urology market is expected to reach an estimated $9.7 billion by 2030 with a CAGR of 6.6% from 2024 to 2030. The major drivers for this market are the rising prevalence of chronic diseases, the increasing number of dialysis patients, and the growing preference for minimally invasive (MI) devices.

• Lucintel forecast that, within the product category, the percutaneous nephrostomy catheter is expected to witness the highest growth over the forecast period due to its significant use in treating problems from kidney transplants, decompressing nephric or perinephric fluid collection, and non-dilated obstructive therapies.
• Within the end-use category, hospitals will remain the largest segment due to the increasing admission of renal disease patients, easy availability of advanced treatment devices, and the growing number of patients obtaining dialysis in medical facilities.
• In terms of regions, North America is expected to witness the highest growth over the forecast period due to the growing number of kidney-affected patients, the presence of skilled physicians, and the availability of well-established healthcare facilities in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Nephrology and Urology Market

Emerging trends in the nephrology and urology market have a bearing on future care given advances in technology as well as changing patient needs.

• Integration of Artificial Intelligence: AI is progressively finding its way into diagnostic systems as well as treatment options available for nephrologists and urologists. AI algorithms are essential in improving diagnostics' accuracy, personalizing treatment plans, as well as enhancing predictive analytics thereby leading to improved patient outcomes.
• Advancements in Minimally Invasive Surgery: The use of minimally invasive techniques such as laparoscopic surgery and robot-assisted surgery has been gaining popularity among surgeons. These approaches minimize complications, hasten recovery, and offer more accurate treatments thus benefiting patients.
• Expansion of Telehealth Services: Telehealth technology is now being used more often by nephrologists and urologists allowing them to provide consultations remotely or monitor their patients over time. This trend makes it easier for all people regardless of their place of living to access healthcare services also simplifying the management of chronic conditions.
• Focus on Personalized Medicine: Personalized medicine is catching on with treatments that fit individual genetic formulae and target specific health conditions. This model intends to maximize therapeutic effectiveness while minimizing side effects by customizing care using patient-specific data.
• Development of Advanced Diagnostic Tools: Improved imaging techniques and biomarker-based tests are being witnessed in the field of diagnostics. These developments enable early detection and more accurate diagnosis of urology and kidney-related ailments.

These trends enhance diagnostic precision, treatment efficiency, and patient reachability; consequently reshaping the nephrology & urology market.

Recent Developments in the Nephrology and Urology Market

Advancements in technology and new treatment methods characterize the recent important developments in the nephrology and urology market.

• Artificial Kidney Technologies: The artificial kidney technologies under development aim at improving dialysis efficiency as well as patients' comfort during therapy procedures. They mainly focus on designing wearable or implantable devices that mimic kidney functions better than ever before.
• Robotic-Assisted Surgeries: Robotic-assisted surgery systems have been introduced into urological practice which has led to a revolution in urological operations. These assistive machines provide a higher level of precision and control, thus reducing complications while also speeding up recovery time.
• Telehealth Integration: Telehealth's growth has improved the management of nephrology and urology at a distance. It is leading to greater patient involvement and increased availability through virtual consultations and remote monitoring tools.
• Advanced Imaging Techniques: Modern imaging techniques, such as high-resolution MRI, and 3D ultrasound are improving diagnosis accuracy and treatment planning for renal and urological diseases.
• Personalized Medicine Approaches: Personalized medicine has been taken up which facilitates individualized therapy based on patient profiles, leading to better outcomes in treatment while minimizing side effects.

These developments are driving innovation and improving the quality of care in nephrology and urology.

Strategic Growth Opportunities for Nephrology and Urology Market

Various applications among others have led to strategic growth opportunities emerging in this field.

• Telemedicine Expansion: A significant avenue for expansion of telemedicine services is offered by increasing care access as well as enhancing patient management. To bridge service gaps reaching underserved populations; robust telehealth platforms should be developed.
• Robotic Surgery Systems: Becoming an investor in robotic surgery systems brings about chances for growth as it provides state-of-the-art surgical solutions. In clinical settings, these systems promote precision and outcomes during urological surgeries.
• Advances in artificial kidney technologies can lead to growth opportunities in the dialysis market. This, therefore, means that innovations aimed at making chronic kidney disease management more effective and convenient would be able to address this unmet need.
• Personalized Treatment Solutions: Growth can result from personalized medicine approaches that utilize such patient data in the field of nephrology and urology. As a result, these developments are expected to improve therapeutic outcomes and satisfaction levels among patients.
• Innovations in Diagnostic Tools: Early detection and monitoring of kidney and urological diseases may be improved through expanding the variety of diagnostic tools available. Consequently, advances in imaging as well as biomarker testing are poised to increase diagnostic accuracy.

These opportunities are shaping the Nephrology and Urology market by driving innovation and improving patient care.

Nephrology and Urology Market Driver and Challenges

The nephrology and urology market is influenced by various drivers, which are also major challenges that affect its growth as well as development.

The factors responsible for driving the nephrology and urology market include:

• Technological Advancements: The use of innovative diagnostic tools, surgical techniques, and digital health solutions drives the increase of this market segment. These improvements lift efficiency as well as effectiveness throughout nephrology care especially when it comes to urologists.
• Rising Incidence of Kidney and Urological Disorders: The increasing prevalence of renal and urogenital conditions is leading to the need for more sophisticated treatment options. This trend pushes forward the development and uptake of new technologies and therapies.
• Growing Focus on Personalized Medicine: A shift toward personalized healthcare has increased successful treatment outcomes by adjusting medical regimens to suit individual patient profiles. Such a method is being recognized in nephrology as well as urology.
• Expansion of Telehealth Services: The increasing growth in telehealth services is enhancing access to care and improving patient management. Nephrology and urology care are beginning to incorporate remote consultation and monitoring.
• Increased Research and Development Investment: This funding promotes the advancement of nephrology as well as urology technologies through investment in research and development. It supports the creation of fresh therapeutic methods and diagnostic tools among other things.

Challenges in the nephrology and urology market are:

• High Costs of Advanced Technologies: High prices for advanced technological devices can act as an obstacle to their adoption. Healthcare providers together with patients face a challenge in striking a balance between cost and accessibility.
• Regulatory and Compliance Issues: Negotiating labyrinthine regulatory requirements while ensuring standards are met can be problematical. They affect issues like entry into the market or clearance for novel products.
• Data Privacy Fears: It is a big task to ensure that patient data security and privacy are observed. To maintain trust, compliance with the rules of data protection and responding to patients' needs are essential.

The nephrology and urology market is being shaped by these driving forces and challenges by affecting innovation, purchase decisions as well as regulatory requirements.

List of Nephrology and Urology Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies nephrology and urology companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the nephrology and urology companies profiled in this report include-

• Medtronic
• Coloplast
• Boston Scientific
• ConvaTec
• B. Braun
• Hollister
• Teleflex
• Baxter
• Fresenius Medical Care
• Asahi Kasei

Nephrology and Urology by Segment

The study includes a forecast for the global nephrology and urology by product, application, end use industry, technology, and region

Nephrology and Urology Market by Product [Analysis by Value from 2018 to 2030]:

• Ureteral Catheters
• PCN Catheters
• Urinary Stents
• Stone Basket
• Urology Guidewires
• Renal Dilators

Nephrology and Urology Market by Application [Analysis by Value from 2018 to 2030]:

• Urolithiasis
• Urological Cancer & BPH
• Bladder Disorders
• Kidney Diseases
• Others

Nephrology and Urology Market by End Use Industry [Analysis by Value from 2018 to 2030]:

• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Others

Nephrology and Urology Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Nephrology and Urology Market

The latest trends in the nephrology and urology market show innovative treatment technologies and a growing global attention to patient-centered care.

• United States: The United States has witnessed significant milestones towards managing kidney diseases including the use of artificial kidneys and improved dialysis techniques. There is also an increasing trend for personalized medical care as well as telehealth solutions meant to enhance patients' outcomes in nephrology and urology.
• China: Technological advancements in China have led to the rapid development of advanced diagnostic tools alongside minimal invasive surgical approaches. These include imaging innovations as well as robotic-assisted surgeries that are increasingly used to improve the efficiency of care processes and reduce recovery periods for patients with nephrological or urological conditions.
• Germany: Germany is leading in digital health integration into nephrology and urology care. Most recently, there have been developments such as advanced telemedicine platforms and electronic health records for adequate management of chronic kidney diseases plus complex urological procedures support.
• India: In India, however, there has been a focus on expanding access to nephrology/urology through affordable options & creation of specialized centers. Consequently, new technologies are being developed while existing ones are being refined so that they can be able to cope with the increasing number of renal disorders & urogenital abnormalities.
• Japan: Japan is at the forefront of developing high-precision diagnostic tools and treatment technologies for nephrology and urology. Recent milestones include state-of-the-art imaging methods and robots with surgical precision that facilitate better results for patients.

Features of the Global Nephrology and Urology Market

Market Size Estimates: Nephrology and urology market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Nephrology and urology market size by product, application, end use industry, and region in terms of value ($B).

Regional Analysis: Nephrology and urology market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, applications, end use industries, and regions for the nephrology and urology market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the nephrology and urology market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the nephrology and urology market by product (ureteral catheters, PCN catheters, urinary stents, stone basket, urology guidewires, renal dilators, and others), application (urolithiasis, urological cancer & BPH, bladder disorders, kidney diseases, and others), end use industry (hospitals, clinics, ambulatory surgical centers, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Nephrology and Urology Market: Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Nephrology and Urology Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Nephrology and Urology Market by Product
  • 3.3.1: Ureteral Catheters
  • 3.3.2: PCN Catheters
  • 3.3.3: Urinary Stents
  • 3.3.4: Stone Basket
  • 3.3.5: Urology Guidewires
  • 3.3.6: Renal Dilators
  • 3.3.7: Others
• 3.4: Global Nephrology and Urology Market by Application
  • 3.4.1: Urolithiasis
  • 3.4.2: Urological Cancer & BPH
  • 3.4.3: Bladder Disorders
  • 3.4.4: Kidney Diseases
  • 3.4.5: Others
• 3.5: Global Nephrology and Urology Market by End Use Industry
  • 3.5.1: Hospitals
  • 3.5.2: Clinics
  • 3.5.3: Ambulatory Surgical Centers
  • 3.5.4: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Nephrology and Urology Market by Region
• 4.2: North American Nephrology and Urology Market
  • 4.2.1: North American Nephrology and Urology Market by Product: Ureteral Catheters, PCN Catheters, Urinary Stents, Stone Basket, Urology Guidewires, Renal Dilators, and Others
  • 4.2.2: North American Nephrology and Urology Market by End Use Industry: Hospitals, Clinics, Ambulatory Surgical Centers, and Others
• 4.3: European Nephrology and Urology Market
  • 4.3.1: European Nephrology and Urology Market by Product: Ureteral Catheters, PCN Catheters, Urinary Stents, Stone Basket, Urology Guidewires, Renal Dilators, and Others
  • 4.3.2: European Nephrology and Urology Market by End Use Industry: Hospitals, Clinics, Ambulatory Surgical Centers, and Others
• 4.4: APAC Nephrology and Urology Market
  • 4.4.1: APAC Nephrology and Urology Market by Product: Ureteral Catheters, PCN Catheters, Urinary Stents, Stone Basket, Urology Guidewires, Renal Dilators, and Others
  • 4.4.2: APAC Nephrology and Urology Market by End Use Industry: Hospitals, Clinics, Ambulatory Surgical Centers, and Others
• 4.5: ROW Nephrology and Urology Market
  • 4.5.1: ROW Nephrology and Urology Market by Product: Ureteral Catheters, PCN Catheters, Urinary Stents, Stone Basket, Urology Guidewires, Renal Dilators, and Others
  • 4.5.2: ROW Nephrology and Urology Market by End Use Industry: Hospitals, Clinics, Ambulatory Surgical Centers, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Nephrology and Urology Market by Product
  • 6.1.2: Growth Opportunities for the Global Nephrology and Urology Market by Application
  • 6.1.3: Growth Opportunities for the Global Nephrology and Urology Market by End Use Industry
  • 6.1.4: Growth Opportunities for the Global Nephrology and Urology Market Region
• 6.2: Emerging Trends in the Global Nephrology and Urology Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Nephrology and Urology Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Nephrology and Urology Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Medtronic
• 7.2: Coloplast
• 7.3: Boston Scientific
• 7.4: ConvaTec
• 7.5: B. Braun
• 7.6: Hollister
• 7.7: Teleflex
• 7.8: Baxter
• 7.9: Fresenius Medical Care
• 7.10: Asahi Kasei